Collaborations and Inclusivity for Equitable DME Care

EP: 1.Addressing Barriers to Health Equity: The Role of Timely Diagnosis and Health Literacy in Managing Diabetic Eye Disease

EP: 2.Challenges in Diabetes Therapy Adherence: Impact on Early Intervention and Long-Term Visual Outcomes

EP: 3.Improving Patient Adherence in Diabetic Macular Edema Eye Care

EP: 4.Impact of Step Therapy and Prior Authorization Requirements in Ophthalmology Practice

EP: 5.Physician Advocacy for Patient Access: Navigating Medication Authorization Challenges

EP: 6.Diversity and Inclusion in Ophthalmology Clinical Trials: Overcoming Challenges and Building Trust

EP: 7.Community Engagement and Long-Term Commitment: Fostering Trust and Collaboration in Clinical Trials for Ophthalmology

EP: 8.Addressing Differences in Social Determinants of Health Among Patients With Diabetes: The Role of Community Engagement

EP: 9.Promoting Equitable Patient Care: A Call for Self-Reflection and Awareness Among Providers

EP: 10.DME Disparities: Socioeconomic Impact and Health Equity

EP: 11.Provider Roles and Collaborative Efforts for DME Disparities

EP: 12.Closing Gaps in DME Care: Harnessing the Power of Comprehensive Data Strategies

EP: 13.Ensuring Equitable Patient Care in DME: Unconscious Bias Training and SDOH Screening

Now Viewing

EP: 14.Collaborations and Inclusivity for Equitable DME Care

EP: 15.Building An Equitable Future: Strategies for DME Advocacy

This is a video synopsis/summary of an Insights involving Amy Nguyen Howell, MD, MBA.

Howell outlines strategies for health care systems and institutions to ensure equitable access for individuals from marginalized communities facing diabetic macular edema (DME). She emphasizes the importance of developing clinical investigators who represent the diversity of patients in clinical trials. Additionally, Howell advocates for increasing diversity in medical education to produce ophthalmologists who understand social determinants of health affecting DME diagnosis and treatment. She also highlights the need for wider availability of treatment options and medications like biosimilars for minority groups.

Addressing partnerships and collaborations, Howell underscores the significance of collective efforts involving health care stakeholders, community groups, and advocacy organizations. Inclusivity is vital, with patients and family caregivers actively participating in discussions to ensure diverse perspectives are heard.

Regarding culturally sensitive environments, Howell suggests health equity officers and health care providers adopt inclusive products and services. Using a health equity lens, employing person-first language, and considering preferred terms for population groups is crucial. Collaborating with communication and marketing teams, using culturally appropriate images, and being aware of unintentional blaming language contribute to creating an inclusive and supportive environment for patients with DME.

Video synopsis is AI-generated and reviewed by AJMC^® editorial staff.